Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: Br J Dermatol. 2022 Jun 2;187(2):223–233. doi: 10.1111/bjd.21060

Figure 3: Treatment response is best observed in perilesional skin at week 12.

Figure 3:

Means of percentage improvement at A) week 12 between perilesional and lesional skin, and B) improvement in perilesional skin between week 4 and week 12. N (%) = number of genes in the hidradenitis suppurativa transcriptome shared with pathway (percentage of total gene in pathway). Stars denote significance with * p ≤ 0.05 ** p ≤ 0.01 *** p ≤ 0.001.